Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting

Andrea K. Miyahira, Joshua M. Lang, Robert B. Den, Isla P. Garraway, Tamara Lotan, Ashley E. Ross, Tanya Stoyanova, Steve Y. Cho, Jonathan W. Simons, Kenneth Pienta, Howard R. Soule

Research output: Contribution to journalArticle

Abstract

Background The 2015 Coffey-Holden Prostate Cancer Academy Meeting, themed: "Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer," was held in La Jolla, California from June 25 to 28, 2015. Methods The Prostate Cancer Foundation (PCF) sponsors an annual, invitation-only, action-tank-structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure. Results The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high-risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi-modal care of high risk and oligometastatic patients. Discussion This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high-risk and oligometastatic prostate cancer patients.

Original languageEnglish (US)
Pages (from-to)125-139
Number of pages15
JournalProstate
Volume76
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Prostatic Neoplasms
Clinical Trials
Molecular Imaging
Tumor Biomarkers
Early Diagnosis
Carcinogenesis
Research Personnel
Technology
Neoplasms
Therapeutics

Keywords

  • biomarkers
  • diagnosis
  • molecular imaging
  • oligometastatic
  • therapeutics

ASJC Scopus subject areas

  • Urology
  • Oncology

Cite this

Multidisciplinary intervention of early, lethal metastatic prostate cancer : Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting. / Miyahira, Andrea K.; Lang, Joshua M.; Den, Robert B.; Garraway, Isla P.; Lotan, Tamara; Ross, Ashley E.; Stoyanova, Tanya; Cho, Steve Y.; Simons, Jonathan W.; Pienta, Kenneth; Soule, Howard R.

In: Prostate, Vol. 76, No. 2, 01.02.2016, p. 125-139.

Research output: Contribution to journalArticle

Miyahira, AK, Lang, JM, Den, RB, Garraway, IP, Lotan, T, Ross, AE, Stoyanova, T, Cho, SY, Simons, JW, Pienta, K & Soule, HR 2016, 'Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting', Prostate, vol. 76, no. 2, pp. 125-139. https://doi.org/10.1002/pros.23107
Miyahira, Andrea K. ; Lang, Joshua M. ; Den, Robert B. ; Garraway, Isla P. ; Lotan, Tamara ; Ross, Ashley E. ; Stoyanova, Tanya ; Cho, Steve Y. ; Simons, Jonathan W. ; Pienta, Kenneth ; Soule, Howard R. / Multidisciplinary intervention of early, lethal metastatic prostate cancer : Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting. In: Prostate. 2016 ; Vol. 76, No. 2. pp. 125-139.
@article{ca52d7cfd7db45f69befe8a737c22eaa,
title = "Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting",
abstract = "Background The 2015 Coffey-Holden Prostate Cancer Academy Meeting, themed: {"}Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,{"} was held in La Jolla, California from June 25 to 28, 2015. Methods The Prostate Cancer Foundation (PCF) sponsors an annual, invitation-only, action-tank-structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure. Results The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high-risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi-modal care of high risk and oligometastatic patients. Discussion This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high-risk and oligometastatic prostate cancer patients.",
keywords = "biomarkers, diagnosis, molecular imaging, oligometastatic, therapeutics",
author = "Miyahira, {Andrea K.} and Lang, {Joshua M.} and Den, {Robert B.} and Garraway, {Isla P.} and Tamara Lotan and Ross, {Ashley E.} and Tanya Stoyanova and Cho, {Steve Y.} and Simons, {Jonathan W.} and Kenneth Pienta and Soule, {Howard R.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1002/pros.23107",
language = "English (US)",
volume = "76",
pages = "125--139",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Multidisciplinary intervention of early, lethal metastatic prostate cancer

T2 - Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting

AU - Miyahira, Andrea K.

AU - Lang, Joshua M.

AU - Den, Robert B.

AU - Garraway, Isla P.

AU - Lotan, Tamara

AU - Ross, Ashley E.

AU - Stoyanova, Tanya

AU - Cho, Steve Y.

AU - Simons, Jonathan W.

AU - Pienta, Kenneth

AU - Soule, Howard R.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Background The 2015 Coffey-Holden Prostate Cancer Academy Meeting, themed: "Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer," was held in La Jolla, California from June 25 to 28, 2015. Methods The Prostate Cancer Foundation (PCF) sponsors an annual, invitation-only, action-tank-structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure. Results The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high-risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi-modal care of high risk and oligometastatic patients. Discussion This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high-risk and oligometastatic prostate cancer patients.

AB - Background The 2015 Coffey-Holden Prostate Cancer Academy Meeting, themed: "Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer," was held in La Jolla, California from June 25 to 28, 2015. Methods The Prostate Cancer Foundation (PCF) sponsors an annual, invitation-only, action-tank-structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure. Results The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high-risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi-modal care of high risk and oligometastatic patients. Discussion This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high-risk and oligometastatic prostate cancer patients.

KW - biomarkers

KW - diagnosis

KW - molecular imaging

KW - oligometastatic

KW - therapeutics

UR - http://www.scopus.com/inward/record.url?scp=84955173528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955173528&partnerID=8YFLogxK

U2 - 10.1002/pros.23107

DO - 10.1002/pros.23107

M3 - Article

C2 - 26477609

AN - SCOPUS:84955173528

VL - 76

SP - 125

EP - 139

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 2

ER -